Adipose tissue as an endocrine organ

Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 Ahima, 2000, Adipose tissue as an endocrine organ, Trends in Endocrinology and Metabolism, 11, 327, 10.1016/S1043-2760(00)00301-5 Mohamed-Ali, 1998, Adipose tissue as an endocrine and paracrine organ, International Journal of Obesity, 22, 1145, 10.1038/sj.ijo.0800770 Coleman, 1973, Effects of parabiosis of obese with diabetes and normal mice, Diabetologia, 9, 294, 10.1007/BF01221857 Prins, 1997, Regulation of adipose cell number in man, Clinical Science, 92, 3, 10.1042/cs0920003 Kissebah, 1994, Regional adiposity and morbidity, Physiological Reviews, 74, 761, 10.1152/physrev.1994.74.4.761 Bergman, 2001, Central role of the adipocyte in the metabolic syndrome, Journal of Investigative Medicine, 49, 119, 10.2310/6650.2001.34108 Sewter, 1999, Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro, Journal of Endocrinology, 163, 33, 10.1677/joe.0.1630033 Ledgerwood, 1998, TNF alpha Hotamisligil, 1994, Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diabetes.43.11.1271 Hotamisligil, 1993, Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 Jequier, 1996, A metabolic perspective on the interaction between obesity and diabetes, Current Opinion in Endocrinology and Diabetes, 3, 10, 10.1097/00060793-199602000-00003 Hotamisligil, 1996, The molecular link between obesity and diabetes, Current Opinion in Endocrinology and Diabetes, 3, 16, 10.1097/00060793-199602000-00004 Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance, Journal of Clinical Investigation, 95, 2409, 10.1172/JCI117936 Kern, 2001, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, American Journal of Physiology, Endocrinology and Metabolism, 280, E745, 10.1152/ajpendo.2001.280.5.E745 Kern, 1995, The expression of tumor necrosis factor in human adipose tissue, Journal of Clinical Investigation, 95, 2111, 10.1172/JCI117899 Katsuki, 1998, Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus, Journal of Clinical Endocrinology and Metabolism, 83, 859, 10.1210/jc.83.3.859 Dandona, 1998, Tumor necrosis factor-α in sera of obese patients: fall with weight loss, Journal of Clinical Endocrinology and Metabolism, 83, 2907, 10.1210/jc.83.8.2907 Löfgren, 2000, Secretion of tumor necrosis factor-α shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue, Diabetes, 49, 688, 10.2337/diabetes.49.5.688 Hube, 1999, Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus, European Journal of Clinical Investigation, 29, 672, 10.1046/j.1365-2362.1999.00520.x Hotamisligil, 2000, Molecular mechanisms of insulin resistance and the role of the adipocyte, International Journal of Obesity, 24, S23, 10.1038/sj.ijo.0801497 Liu, 1998, Tumor necrosis factor α acutely inhibits insulin signaling in human adipocytes, Diabetes, 47, 515, 10.2337/diabetes.47.4.515 Peraldi, 1996, Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase, Journal of Biological Chemistry, 271, 13018, 10.1074/jbc.271.22.13018 Hube, 2000, The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture, Endocrinology, 141, 2582, 10.1210/en.141.7.2582 Stephens, 1997, Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin-receptor-mediated signal transduction, Journal of Biological Chemistry, 272, 971, 10.1074/jbc.272.2.971 Kanety, 1995, Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1), Journal of Biological Chemistry, 270, 237780, 10.1074/jbc.270.40.23780 Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance, Science, 271, 665, 10.1126/science.271.5249.665 Hotamisligil, 1994, Tumor necrosis factor α inhibits signaling from the insulin receptor, Proceedings of the National Academy of Sciences of the USA, 91, 4854, 10.1073/pnas.91.11.4854 Ranganathan, 1996, Effect of tumor necrosis factor-α on basal and insulin-stimulated glucose transport in cultured muscle and fat cells, Metabolism, 45, 1089, 10.1016/S0026-0495(96)90007-4 Uysal, 1997, Protection from obesity-induced insulin resistance in mice lacking TNF-α function, Nature, 389, 610, 10.1038/39335 Scheen, 1996, Neutralization of TNFα in obese insulin-resistant human subjects: no effect on insulin sensitivity, Diabetes, 45, 286A Ofei, 1996, Effects of engineered human anti-TNFα antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM, Diabetes, 45, 881, 10.2337/diabetes.45.7.881 Petruschke, 1993, Tumor Necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells, Journal of Clinical Endocrinology and Metabolism, 76, 742, 10.1210/jc.76.3.742 Prins, 1997, Tumor necrosis factor-α induces apoptosis of human adipose cells, Diabetes, 46, 1939, 10.2337/diabetes.46.12.1939 Hauner, 1995, Effects of tumour necrosis factor alpha (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat cells in culture, Diabetologia, 38, 764, 10.1007/s001250050350 van der Poll, 1991, Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans, American Journal of Physiology, 261, E457 Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo, Journal of Clinical Endocrinology and Metabolism, 82, 4196, 10.1210/jc.82.12.4196 Jones, 1994, Interleukin-6: an endocrine cytokine, Clinical Endocrinology, 40, 703, 10.1111/j.1365-2265.1994.tb02502.x Vozarova, 2001, Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion, Obesity Research, 9, 414, 10.1038/oby.2001.54 Fried, 1998, Omental and subcutaneous adipose tissue depots of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, Journal of Clinical Endocrinology and Metabolism, 83, 847, 10.1210/jc.83.3.847 Bastard, 2000, Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss, Journal of Clinical Endocrinology and Metabolism, 85, 3338, 10.1210/jc.85.9.3338 Wallenius, 2002, Interleukin-6-deficient mice develop mature-onset obesity, Nature Medicine, 8, 75, 10.1038/nm0102-75 Choy, 1992, Adipsin and an endogenous pathway of complement from adipose cells, Journal of Biological Chemistry, 267, 12736, 10.1016/S0021-9258(18)42338-1 Flier, 1987, Severely impaired adipsin expression in genetic and acquired obesity, Science, 237, 405, 10.1126/science.3299706 Rosen, 1989, Adipsin and complement factor D activity: an immune-related defect in obesity, Science, 244, 1483, 10.1126/science.2734615 Napolitano, 1994, Concentration of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass, International Journal of Obesity, 18, 213 Sniderman, 2000, Of mice and men (and women) and the acylation-stimulating protein pathway, Current Opinion in Lipidology, 11, 291, 10.1097/00041433-200006000-00010 Baldo, 1993, The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis, Journal of Clinical Investigation, 92, 1543, 10.1172/JCI116733 Murray, 2000, Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein, Endocrinology, 141, 1041, 10.1210/en.141.3.1041 Biesma, 2001, A family with complement factor D deficiency, Journal of Clinical Investigation, 108, 233, 10.1172/JCI200112023 Shimomura, 1994, Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity, Nature Medicine, 2, 800, 10.1038/nm0796-800 Morange, 1999, Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue, Diabetes, 48, 890, 10.2337/diabetes.48.4.890 Kato, 1999, Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: a possible role for PPARγ in endothelial function, Biochemical and Biophysical Research Communications, 258, 431, 10.1006/bbrc.1999.0648 Marx, 1999, PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression, Thrombosis and Vascular Biology, 19, 546, 10.1161/01.ATV.19.3.546 Karlsson, 1998, Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II, Journal of Clinical Endocrinology and Metabolism, 83, 3925, 10.1210/jc.83.11.3925 Morris, 1996, Angiotensin II: an insulin-sensitizing vasoactive hormone?, Journal of Clinical Endocrinology and Metabolism, 81, 1303, 10.1210/jc.81.4.1303 Jones, 1997, Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells, Endocrinology, 138, 1512, 10.1210/en.138.4.1512 Frederich, 1992, Tissue-specific nutritional regulation of angiotensinogen in adipose tissue, Hypertension, 19, 339, 10.1161/01.HYP.19.4.339 Abel, 2001, Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver, Nature, 409, 729, 10.1038/35055575 Kraegan, 1999, The role of free fatty acids in muscle insulin resistance, 141 van Epps-Fung, 1997, Fatty acid-induced insulin resistance in adipocytes, Endocrinology, 138, 4338, 10.1210/en.138.10.4338 Storlein, 1997, Fatty acids, triglycerides and syndromes of insulin resistance, Prostaglandins, Leukotrienes and Essential Fatty Acids, 57, 379, 10.1016/S0952-3278(97)90414-2 Boden, 1995, Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes, Journal of Clinical Investigation, 96, 1261, 10.1172/JCI118160 Bollheimer, 1998, Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation, Journal of Clinical Investigation, 101, 1094, 10.1172/JCI420 Dobbins, 1998, A fatty acid-dependent step is critically important for both glucose- and non-glucose stimulated insulin secretion, Journal of Clinical Investigation, 101, 2370, 10.1172/JCI1813 Rebrin, 1995, Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin, Diabetes, 44, 1038, 10.2337/diabetes.44.9.1038 Oakes, 1997, Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding, Diabetes, 46, 1768, 10.2337/diabetes.46.11.1768 Hansen, 1998, A high fat diet impairs insulin stimulation of glucose transport in muscle, Journal of Biological Chemistry, 273, 26157, 10.1074/jbc.273.40.26157 Dresner, 1999, Effects of free fatty acids of glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity, Journal of Clinical Investigation, 103, 253, 10.1172/JCI5001 Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ, Proceedings of the National Academy of Sciences of the USA, 94, 4318, 10.1073/pnas.94.9.4318 Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and γ, Proceedings of the National Academy of Sciences of the USA, 94, 4312, 10.1073/pnas.94.9.4312 Desvergne, 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocrine Reviews, 20, 649, 10.1210/er.20.5.649 Kahn, 2000, Obesity and insulin resistance, Journal of Clinical Investigation, 106, 473, 10.1172/JCI10842 Oakes, 2001, Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability, Diabetes, 50, 1158, 10.2337/diabetes.50.5.1158 Miyazaki, 2001, Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients, Diabetologia, 44, 2210, 10.1007/s001250100031 Pan, 1995, Skeletal muscle membrane lipid composition is related to adiposity and insulin action, Journal of Clinical Investigation, 96, 2802, 10.1172/JCI118350 Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, Journal of Biological Chemistry, 271, 10697, 10.1074/jbc.271.18.10697 Arita, 1999, Paradoxical decrease on an adipose-specific protein, adiponectin, in obesity, Biochemical and Biophysical Research Communications, 257, 79, 10.1006/bbrc.1999.0255 Combs, 2001, Endogenous glucose production is inhibited by the adipose-derived protein Acrp30, Journal of Clinical Investigation, 108, 1875, 10.1172/JCI14120 Berg, 2002, ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism, Trends in Endocrinology and Metabolism, 13, 84, 10.1016/S1043-2760(01)00524-0 Berg, 2001, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nature Medicine, 7, 947, 10.1038/90992 Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nature Medicine, 7, 941, 10.1038/90984 Maeda, 2001, PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein, Diabetes, 50, 2094, 10.2337/diabetes.50.9.2094 Steppan, 2001, The hormone resistin links obesity to diabetes, Nature, 409, 307, 10.1038/35053000 Way, 2001, Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists, Journal of Biological Chemistry, 276, 25651, 10.1074/jbc.C100189200 Smith, 2002, Resistin – resistant to defining its role, Obesity Research, 10, 61, 10.1038/oby.2002.9 Savage, 2001, Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans, Diabetes, 50, 2199, 10.2337/diabetes.50.10.2199 Janke, 2002, Resistin gene expression in human adipocytes is not related to insulin resistance, Obesity Research, 10, 1, 10.1038/oby.2002.1 Flier, 1998, Obesity and the hypothalamus: novel peptides for new pathways, Cell, 92, 437, 10.1016/S0092-8674(00)80937-X Ollmann, 1997, Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein, Science, 278, 135, 10.1126/science.278.5335.135 Klebig, 1995, Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur, Proceedings of the National Academy of Sciences of the USA, 92, 4728, 10.1073/pnas.92.11.4728 Voisey, 2002, BMI-related human adipocyte agouti expression is sex-specific but not anatomically depot-specific, Obesity Research, 10.1038/oby.2002.62 Montague, 1997, Congenital leptin deficiency is associated with severe early-onset obesity in humans, Nature, 387, 903, 10.1038/43185 Farooqi, 1999, Effects of recombinant leptin therapy in a child with congenital leptin deficiency, New England Journal of Medicine, 341, 879, 10.1056/NEJM199909163411204 Oral, 2002, Leptin-replacement therapy for lipodystrophy, New England Journal of Medicine, 346, 570, 10.1056/NEJMoa012437 Stewart, 1999, Cortisol metabolism in human obesity: impaired cortisone to cortisol conversion in subjects with central adiposity, Journal of Clinical Endocrinology and Metabolism, 84, 1022, 10.1210/jc.84.3.1022 Bujalska, 1997, Does central obesity reflect ‘Cushing's disease of the omentum’?, Lancet, 349, 1210, 10.1016/S0140-6736(96)11222-8